GLP-1 is generally prescribed for adults with a BMI over 30, or over 27 with conditions like diabetes, high blood pressure, or high cholesterol
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda, Victoza), are increasingly prescribed for type 2 diabetes management and weight loss in the UK
Gitlin MJ
Phospholipase D1 has a pivotal role in interleukin-1beta-driven chronic autoimmune arthritis through regulation of NF-kappaB, hypoxia-inducible factor 1alpha, and FoxO3a
At 208 weeks, semaglutide was associated with mean reduction in weight (10.2%), waist circumference (7.7 cm) and waist-to-height ratio (6.9%) versus placebo (1.5%, 1.3 cm and 1.0%, respectively